Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105 USD | -1.58% | -1.63% | +13.79% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 431M | Sales 2025 * | 653M | Capitalization | 6.57B |
---|---|---|---|---|---|
Net income 2024 * | -152M | Net income 2025 * | -104M | EV / Sales 2024 * | 14.1 x |
Net cash position 2024 * | 514M | Net cash position 2025 * | 444M | EV / Sales 2025 * | 9.39 x |
P/E ratio 2024 * |
-47.1
x | P/E ratio 2025 * |
-64
x | Employees | 645 |
Yield 2024 * |
-
| Yield 2025 * |
0.95% | Free-Float | 99.1% |
Latest transcript on Blueprint Medicines Corporation
1 day | -1.58% | ||
1 week | -1.63% | ||
Current month | +14.91% | ||
1 month | +18.07% | ||
3 months | +16.29% | ||
6 months | +64.88% | ||
Current year | +13.79% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 105 | -1.58% | 415,572 |
24-05-16 | 106.6 | -0.14% | 411,483 |
24-05-15 | 106.8 | +1.26% | 758,088 |
24-05-14 | 105.5 | -2.40% | 582,058 |
24-05-13 | 108 | +1.27% | 383,987 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.79% | 6.57B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- BPMC Stock